Skip to content
healthcare.dev

Potassium Chloride for Oral Solution

NDC 10135-819, Potassium Chloride for Oral Solution, solution, from Marlex Pharmaceuticals Inc.

Product NDC
10135-819
Status
Listed
Labeler
Marlex Pharmaceuticals Inc
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212183
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-819 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POTASSIUM CHLORIDE1.5 g/1.58g

Pharmacologic classes

Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]

Package NDCNDC-11Package
10135-819-08101350819081.58 g in 1 BOTTLE (10135-819-08)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3e78028d-21a0-ba0f-e063-6294a90aac49

Use it

Look up 10135-819 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-819 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-819. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.